Share Prices & Company Research

Market News

10 Feb 2021 | 10:18

Nuformix seeks chairman as Blackwell quits after a year

(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company. Nuformix said it had started looking for a new chairman after Blackwell stepped down with immediate effect "due to personal reasons that require his immediate attention".

Blackwell became interim chairman in February 2020 when Dave Tapolczay left abruptly and became executive chairman in June when Dan Gooding stepped down as chief executive. He oversaw the appointment of Anne Brindley as CEO in December when he went back to being non-executive chairman.

Brindley said: "Along with the rest of the board, I would like to thank Chris for his contribution to the company and we give him our very best wishes. I have enjoyed working closely with Chris."

She said she would set out her plans for the company in the coming weeks. Nuformix shares fell 3.3% to 2.52p at 10:56 GMT and have almost halved in the past year.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 14th May 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.